Sign In
Buy AIM
$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
AIM ImmunoTech’s CEO to Present at the Planet Microcap Showcase Virtual Investor Conference 2020
10:30am, Monday, 20'th Apr 2020
OCALA, FL / ACCESSWIRE / April 20, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral dis
Cadila Healthcare at the forefront, looks at biologic drug to treat Covid
06:55am, Monday, 20'th Apr 2020
Company is already working on developing 2 vaccine candidates, diagnostic kits and also making HCQ
Head to Head Comparison: BioCryst Pharmaceuticals (NASDAQ:BCRX) vs. AIM ImmunoTech (NASDAQ:AIM)
06:06am, Sunday, 12'th Apr 2020
BioCryst Pharmaceuticals (NASDAQ:BCRX) and AIM ImmunoTech (NYSE:AIM) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of
AIM Stock Is a Moonshot That Lacks the Fuel
12:26pm, Thursday, 09'th Apr 2020
Despite a relevant search for a coronavirus treatment, AIM ImmunoTech faces steep competition and questions regarding credibility.
Ignore the Coronavirus Catalyst for ABBV Stock
02:03pm, Wednesday, 08'th Apr 2020
AbbVie servers patients with serious conditions and these are exactly the people who are most at risk during this pandemic.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.) * Forty Seven Inc (NASDAQ: FTSV) * Masimo Corporat
OCALA, FL / ACCESSWIRE / April 6, 2020 / AIM ImmunoTech (NYSE American:AIM) today announced it has entered into a Material Transfer and Research Agreement (MTA) with Shenzhen Smoore Technology Limited
OCALA, FL / ACCESSWIRE / April 6, 2020 / The National Cancer Institute issued an award of $14.54 million to Roswell Park Comprehensive Cancer Center to test chemokine modulation incorporating AIM Immu
Don’t Pull the Trigger on AIM ImmunoTech Stock
07:06pm, Thursday, 02'nd Apr 2020
If it sounds too good to be true, it probably is. And that's likely the case when you look deeper into what's going on with AIM stock.
AIM Stock: You’ve Got a Better Shot of Getting Rich Buying a Lottery Ticket
01:44pm, Thursday, 02'nd Apr 2020
AIM ImmunoTech reported its 2019 results on March 31. Despite the coronavirus push, AIM stock headed lower on the news.
HAL, APA among premarket gainers
01:17pm, Tuesday, 31'st Mar 2020
SG Blocks (NASDAQ:SGBX) +100% on Q4 results.EyeGate Pharmaceuticals (NASDAQ:EYEG) +51% on positive dry eye data.Kiniksa Pharmaceuticals (NASDAQ:KNSA) +39% as mavrilimumab shows treatment response i
AIM ImmunoTech Reports 2019 Year-end Financial Results
10:45am, Tuesday, 31'st Mar 2020
OCALA, FL / ACCESSWIRE / March 31, 2020 / AIM ImmunoTech (NYSE American:AIM) announces financial results for the fiscal year ended December 31, 2019, and provides a business update. Research and deve
55 Stocks Moving In Monday's Mid-Day Session
04:49pm, Monday, 30'th Mar 2020
Gainers
SuperCom Ltd. (NASDAQ: SPCB) shares climbed 202% to $1.48 after the company announced it has shipped Coronavirus quarantine compliance technology for an immediate pilot....
ABT, DD among premarket gainers
01:22pm, Monday, 30'th Mar 2020
Plus Therapeutics. (NASDAQ:PSTV) +63% in-licenses novel oncology candidates.Bellerophon Therapeutics (NASDAQ:BLPH) +40% as first COVID-19 patient has been treated with the INOpulse inhaled nitric o
In the Coronavirus Vaccine Race, AIM Stock Isn’t a Likely Winner
10:40am, Friday, 27'th Mar 2020
AIM stock was a big winner on hopes it could join the response to the coronavirus. But its history suggests those hopes are too optimistic.
